Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
| dc.contributor.author | Sanna Toppila-Salmi | |
| dc.contributor.author | Sophie Scheire | |
| dc.contributor.author | Thibaut Van Zele | |
| dc.contributor.author | Job F M van Boven | |
| dc.contributor.author | Mika J. Mäkelä | |
| dc.contributor.author | Laura Pujols | |
| dc.contributor.author | Peter Hellings | |
| dc.contributor.author | Koen Boussery | |
| dc.contributor.author | Isam Alobid | |
| dc.contributor.author | Ralph Mösges | |
| dc.contributor.author | Philippe Gevaert | |
| dc.contributor.author | Martin Wagemann | |
| dc.contributor.author | Carmen Rondon | |
| dc.contributor.author | P. V. Tomazic | |
| dc.contributor.author | Claire Hopkins | |
| dc.contributor.author | Ioana Agache | |
| dc.contributor.author | Wytske Fokkens | |
| dc.contributor.author | Claus Bachert | |
| dc.contributor.author | Kristian Aasbjerg | |
| dc.contributor.author | Michael Rudenko | |
| dc.contributor.author | Arnout Jordens | |
| dc.contributor.author | Valérie Hox | |
| dc.contributor.author | Joaquim Mullol | |
| dc.contributor.author | Paloma Campo | |
| dc.contributor.author | Ludger Klimek | |
| dc.contributor.author | Evelijn Lourijsen | |
| dc.contributor.author | Glenis Scadding | |
| dc.control.author | Claus Bachert | |
| dc.date.accessioned | 2025-06-19T16:23:39Z | |
| dc.date.available | 2025-06-19T16:23:39Z | |
| dc.date.issued | 2020-01-03 | |
| dc.description.abstract | <jats:title>Abstract</jats:title><jats:p>Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that—potentially severe—side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.</jats:p> | |
| dc.description.volume | 10 | |
| dc.identifier.doi | 10.1186/s13601-019-0303-6 | |
| dc.identifier.handle | 10668/3699 | |
| dc.identifier.handle | 2445/151863 | |
| dc.identifier.handle | 11370/f613766b-aab4-4e82-9ce0-674c0fafae65 | |
| dc.identifier.handle | 2078.1/227171 | |
| dc.identifier.handle | 2078.1/263157 | |
| dc.identifier.handle | 10138/313348 | |
| dc.identifier.handle | 10668/24974 | |
| dc.identifier.handle | 20.500.12105/17988 | |
| dc.identifier.handle | 1854/LU-8650078 | |
| dc.identifier.issn | 2045-7022 | |
| dc.identifier.openaire | doi_dedup___:faf600bc4193d2045db6743484507c52 | |
| dc.identifier.pmc | PMC6941282 | |
| dc.identifier.pmid | 31908763 | |
| dc.identifier.uri | https://ror.circle-u.eu/handle/123456789/1340906 | |
| dc.openaire.affiliation | UCLouvain | |
| dc.openaire.collaboration | 1 | |
| dc.publisher | Wiley | |
| dc.rights | OPEN | |
| dc.rights.license | CC BY | |
| dc.source | Clinical and Translational Allergy | |
| dc.subject | medical literature | |
| dc.subject | evidence based medicine | |
| dc.subject | Medical Subject Headings | |
| dc.subject | Rhinosinusitis | |
| dc.subject | Medical Subject Headings | |
| dc.subject | adverse event | |
| dc.subject | gastrointestinal symptom | |
| dc.subject | otorhinolaryngology | |
| dc.subject | eye disease | |
| dc.subject | Review | |
| dc.subject | nose polyp | |
| dc.subject | mental disease | |
| dc.subject | systemic therapy | |
| dc.subject | Medical Subject Headings | |
| dc.subject | DOUBLE-BLIND | |
| dc.subject | Adrenal Cortex Hormones | |
| dc.subject | cardiovascular disease | |
| dc.subject | ORAL STEROIDS | |
| dc.subject | lipid metabolism | |
| dc.subject | Medicine and Health Sciences | |
| dc.subject | SEVERE NASAL POLYPOSIS | |
| dc.subject | Cushingoid syndrome | |
| dc.subject | Medical Subject Headings | |
| dc.subject | Rinitis | |
| dc.subject | Rhinitis | |
| dc.subject | acute rhinosinusitis | |
| dc.subject | alternative medicine | |
| dc.subject | drug effect | |
| dc.subject | CORTICOSTEROID-THERAPY | |
| dc.subject | immunosuppressive treatment | |
| dc.subject | nose disease | |
| dc.subject | Glucocorticosteroids | |
| dc.subject | General medicine, internal medicine and other clinical medicine | |
| dc.subject | risk benefit analysis | |
| dc.subject | ALLERGIC RHINITIS | |
| dc.subject | priority journal | |
| dc.subject | protein metabolism | |
| dc.subject | SEASONAL | |
| dc.subject | diabetes mellitus | |
| dc.subject | drug induced disease | |
| dc.subject | endocrine disease | |
| dc.subject | BONE-MINERAL DENSITY | |
| dc.subject | ENDOSCOPIC SINUS SURGERY | |
| dc.subject | pediatric patient | |
| dc.subject | SEASONAL ALLERGIC RHINITIS | |
| dc.subject | hypothalamus hypophysis adrenal system | |
| dc.subject | injection site discomfort | |
| dc.subject | drug cost | |
| dc.subject | desensitization | |
| dc.subject | review | |
| dc.subject | autoimmune disease | |
| dc.subject | fungal sinusitis | |
| dc.subject | Pólipos nasales | |
| dc.subject | Nasal Polyps | |
| dc.subject | WEGENERS-GRANULOMATOSIS | |
| dc.subject | drug activity | |
| dc.subject | rhinitis | |
| dc.subject | short course therapy | |
| dc.subject | drug mechanism | |
| dc.subject | Humans | |
| dc.subject | carbohydrate metabolism | |
| dc.subject | human | |
| dc.subject | Sinusitis | |
| dc.subject | Glucocorticoides | |
| dc.subject | Glucocorticoids | |
| dc.subject | Corticoesteroides | |
| dc.subject | avascular necrosis | |
| dc.subject | peptic ulcer | |
| dc.subject | Medical Subject Headings | |
| dc.subject | drug use | |
| dc.subject | long term care | |
| dc.subject | allergic rhinitis | |
| dc.subject | calcium balance | |
| dc.subject | hypophysis disease | |
| dc.subject | chronic rhinosinusitis | |
| dc.subject | Medical Subject Headings | |
| dc.subject | antiinflammatory activity | |
| dc.subject | asthma | |
| dc.subject | RC581-607 | |
| dc.subject | osteoporosis | |
| dc.subject | infection | |
| dc.subject | RHEUMATOID-ARTHRITIS | |
| dc.subject | drug efficacy | |
| dc.subject | hypothalamus disease | |
| dc.subject | upper respiratory tract infection | |
| dc.subject | occupational disease | |
| dc.subject | glucocorticoid | |
| dc.subject | GLUCOCORTICOID-RECEPTOR-ALPHA | |
| dc.subject | hyperglycemia | |
| dc.subject | Immunologic diseases. Allergy | |
| dc.subject.fos | 0302 clinical medicine | |
| dc.subject.fos | 03 medical and health sciences | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper | |
| dc.type | publication |